"We will do whatever it takes to develop a safe and effective mRNA-based malaria vaccine that ... purchase of Kite Pharma's T cell receptor (TCR) platform for solid tumours. It started the first ...

Investigators assessed vaccine-induced T cell responses using ex vivo IFNγ ELISpot assays, T cell receptor (TCR) sequencing ... The potential of adjuvant mRNA–lipoplex neoantigen vaccines ...

SINGAPORE, Feb. 11, 2025 /PRNewswire/ -- On 12 Feb 2025 (Singapore Time), Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance ...